Tilray Brands, Inc. (2HQ.DE)
EUR 0.41
(-3.15%)
EUR 0.41
(-3.15%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 252.08 Million USD | 25.7% |
| 2022 | 200.55 Million USD | -18.32% |
| 2021 | 245.52 Million USD | -4.25% |
| 2020 | 256.42 Million USD | 34.57% |
| 2019 | 190.56 Million CAD | 181.69% |
| 2018 | 67.64 Million CAD | 293.82% |
| 2017 | 17.17 Million CAD | 495.41% |
| 2016 | 2.88 Million CAD | 80.14% |
| 2015 | 1.6 Million CAD | 15.44% |
| 2014 | 1.38 Million CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 264.29 Million USD | 15.72% |
| 2023 Q3 | 244.13 Million USD | -3.39% |
| 2023 Q4 | 252.08 Million USD | 3.26% |
| 2023 FY | 252.08 Million USD | 25.7% |
| 2023 Q1 | 232.07 Million USD | 15.72% |
| 2023 Q2 | 252.7 Million USD | 8.89% |
| 2022 Q3 | 202.8 Million USD | -15.83% |
| 2022 Q1 | 244.65 Million USD | -0.36% |
| 2022 FY | 200.55 Million USD | -18.32% |
| 2022 Q4 | 200.55 Million USD | -1.11% |
| 2022 Q2 | 240.94 Million USD | -1.52% |
| 2021 Q3 | 273.29 Million USD | 17.28% |
| 2021 Q1 | 251.5 Million USD | -1.92% |
| 2021 FY | 245.52 Million USD | -4.25% |
| 2021 Q4 | 245.52 Million USD | -10.16% |
| 2021 Q2 | 233.02 Million USD | -7.35% |
| 2020 FY | 256.42 Million USD | 34.57% |
| 2020 Q2 | 269.89 Million USD | 2.73% |
| 2020 Q3 | 267.5 Million CAD | -0.89% |
| 2020 Q4 | 256.42 Million USD | -4.14% |
| 2020 Q1 | 262.71 Million USD | 37.86% |
| 2019 FY | 190.56 Million CAD | 181.69% |
| 2019 Q3 | 168.56 Million USD | 47.19% |
| 2019 Q2 | 114.52 Million USD | 35.48% |
| 2019 Q4 | 190.56 Million USD | 13.05% |
| 2019 Q1 | 84.53 Million USD | 24.96% |
| 2018 Q1 | 26.75 Million USD | 55.77% |
| 2018 Q2 | 30.38 Million USD | 13.55% |
| 2018 Q4 | 67.64 Million USD | 3.14% |
| 2018 Q3 | 65.58 Million USD | 115.87% |
| 2018 FY | 67.64 Million CAD | 293.82% |
| 2017 Q3 | 9.2 Million USD | 36.09% |
| 2017 Q2 | 6.76 Million USD | 43.08% |
| 2017 Q1 | 4.72 Million CAD | 63.89% |
| 2017 FY | 17.17 Million CAD | 495.41% |
| 2017 Q4 | 17.17 Million USD | 86.58% |
| 2016 Q4 | 2.88 Million CAD | 43.35% |
| 2016 Q2 | 2.14 Million CAD | 2.64% |
| 2016 Q1 | 2.08 Million CAD | 30.2% |
| 2016 FY | 2.88 Million CAD | 80.14% |
| 2016 Q3 | 2.01 Million CAD | -5.96% |
| 2015 FY | 1.6 Million CAD | 15.44% |
| 2015 Q1 | 1.55 Million CAD | 11.96% |
| 2015 Q2 | 1.51 Million CAD | -2.65% |
| 2015 Q3 | 1.34 Million CAD | -10.75% |
| 2015 Q4 | 1.6 Million CAD | 18.67% |
| 2014 Q4 | 1.38 Million CAD | 92.35% |
| 2014 FY | 1.38 Million CAD | 0.0% |
| 2014 Q3 | 721.28 Thousand CAD | 81.31% |
| 2014 Q2 | 397.82 Thousand CAD | 3094.59% |
| 2014 Q1 | 12.45 Thousand CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| MPH Health Care AG | - EUR | -Infinity% |
| Apontis Pharma AG | 6.6 Million EUR | -3719.5% |
| Dermapharm Holding SE | 320.75 Million EUR | 21.409% |
| Evotec SE | 30.89 Million EUR | -716.08% |
| MERCK Kommanditgesellschaft auf Aktien | 4.63 Billion EUR | 94.564% |
| PharmaSGP Holding SE | 10.11 Million EUR | -2391.717% |
| SynBiotic SE | 2.76 Million EUR | -9018.4% |